As of 9:30 AM on the 28th, Celltrion is trading at 307,500 KRW, up 0.99% from the previous day. This represents a 3.71% increase compared to July 31. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Over the past five days, individual investors have net bought 183,740 shares, while foreigners and institutions have net sold 49,388 shares and 143,521 shares, respectively.


On August 26, Celltrion was a market topic for its "strength following the approval of Phase 1 clinical trials for a COVID-19 treatment."



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing